ArticleBiochemical pharmacology2011

Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells.

Jayashree P Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.